This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Zhejiang Meton Pharmaceutical Co., Ltd. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Jianxin Yang: Innovator in Cancer Treatment
Introduction
Jianxin Yang is a prominent inventor based in Princeton, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for cancer. His innovative work has led to the creation of a patent that addresses critical health challenges.
Latest Patents
Jianxin Yang holds a patent for an ISO-citrate dehydrogenase (IDH) inhibitor. This patent discloses compounds that inhibit the conversion of α-KG to D-2-HG, along with pharmaceutically acceptable salts, hydrates, solvates, or stereoisomers thereof. The pharmaceutical compositions comprising these compounds can effectively treat IDH-associated diseases, including cancer. He has 1 patent to his name.
Career Highlights
Jianxin Yang is associated with Zhejiang Meton Pharmaceutical Co., Ltd., where he continues to work on innovative solutions in the pharmaceutical industry. His expertise and dedication to research have positioned him as a valuable asset in the fight against cancer.
Collaborations
Jianxin Yang collaborates with talented individuals such as Jibin Yang and Feng Yan. Their combined efforts contribute to the advancement of pharmaceutical research and development.
Conclusion
Jianxin Yang's work in developing IDH inhibitors showcases his commitment to improving cancer treatment options. His innovative contributions are paving the way for future advancements in the pharmaceutical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile